Ingestible beauty - collagen drinks, hyaluronic acid gummies, ingestible SPF capsules, skin-focused probiotics - is one of the fastest-growing corners of the industry. Global category revenue crossed £2.4bn in 2025 and is projected to more than double by 2028. The UK market is growing faster than the global average.
It is also a category where a surprising number of launches get pulled within months. Not because the products do not sell, but because the founders underestimated the regulatory stack.
Here is the honest operator's guide.
Three regulatory frames that apply
A UK ingestible beauty product sits inside at least three overlapping regulatory regimes.
Food Standards Agency (FSA) general food law. Your product is a food, legally. Everything an ordinary food has to comply with (microbiological limits, allergen labelling, traceability, origin labelling) applies to your ingestible. If it crosses into medicinal claims, it jumps up to MHRA jurisdiction, and that is a ten-figure compliance ladder you do not want to climb by accident.
Novel food authorisation. Any ingredient that was not commonly consumed in the UK before 15 May 1997 has to be authorised as a novel food before you can legally sell it. This catches a lot of ingestible beauty founders by surprise: CBD products, certain peptide isolates, some marine collagen preparations, exotic mushroom extracts. If your hero ingredient is on the novel list without authorisation, you cannot sell it. A product can sit in a warehouse for 14 months waiting for an application to clear.
GB Food Information to Consumers (FIC) labelling. Your front-of-pack, back-of-pack and online product description all have to comply with specific labelling rules. Nutrition declaration, allergen emphasis, quantitative ingredient declarations, legal product name. If your beautiful packaging omits any of these, the first Trading Standards visit becomes expensive.
The claims problem
The commercially interesting claims in this category are the ones closest to the regulatory line.
"Supports collagen synthesis" is fine if substantiated. "Boosts collagen" is iffy. "Reverses collagen loss" is a medicinal claim you cannot make. "Clinically proven to reduce wrinkles" is a medicinal claim unless you have a very specific, properly conducted clinical trial and regulatory pre-clearance.
Three principles to live by.
Structure-function only. Claims should describe how your ingredient supports normal physiological function. "Contributes to normal skin" is allowed (if you have the right ingredient at the right dose). "Treats acne" is not.
Substantiate every claim. Every claim on pack, on site, and in any ad creative needs a substantiation file. This is a simple document: what the claim is, what the evidence is, where the dossier lives. Trading Standards and the ASA can ask for this. "We saw it on another brand's site" is not a defence.
Creator briefing is a compliance surface. The creators your brand briefs can make claims you cannot. The ASA has recently ruled that the brand is responsible for influencer claims. Build claims handrails into every brief and every contract. The enforcement risk sits with you.
Novel food, three questions worth answering first
One. Is your hero ingredient on the GB Novel Food list? The FSA publishes a live list. Check yours against it before committing to formulation.
Two. If it is, does it already have authorisation, or are you relying on a pending application? Pending applications are effectively deal-blockers. You cannot launch until clearance.
Three. If you are using an ingredient that has been authorised under someone else's application, do you have access to that authorisation? Many novel food authorisations are applicant-specific. Using the ingredient without the right IP access is not legal.
The pre-launch checklist that saves founders
Four documents, all of which should exist before you invest in packaging.
- Novel food compliance note: one-pager per ingredient, listing status and authorisation reference
- Claims substantiation pack: one per on-pack and on-site claim, with evidence cited
- GB FIC labelling check: a filled-in labelling template for every SKU, signed off by a consultant
- Creator brief guardrails: a list of what creators can and cannot say in your content, in plain English
These four will cost you £2k - £6k in consultant time. A Trading Standards visit without them costs you the launch.
The short version
Ingestible beauty is a real, growing, commercially attractive category in the UK. The brands that grow in it are the ones who treat regulation as a first-quarter cost, not a last-quarter problem. Get your compliance stack right before you ship the hero product and the rest of the launch will feel dramatically easier.